Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 51Neoplasm Metastasis 19Skin Neoplasms 15Carcinoma, Renal Cell 13Leukemia, Myeloid, Acute 12Kidney Neoplasms 11Leukemia 9Neoplasms 7Uterine Cervical Neoplasms 5Lymphoma 5Congenital Abnormalities 5Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neuroblastoma 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Carcinoma, Non-Small-Cell Lung 4Vaginal Neoplasms 2Penile Neoplasms 2Papillomavirus Infections 2Oropharyngeal Neoplasms 2Melanoma, Experimental 2Lymphoma, Mantle-Cell 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Erythroblastic, Acute 2Brain Neoplasms 2

Interventions

Cyclophosphamide 13Doxorubicin 9Trastuzumab 8Taxes 7Paclitaxel 7Docetaxel 5Carboplatin 5Albumin-Bound Paclitaxel 5Radiotherapy 4Epirubicin 4pertuzumab 3pembrolizumab 3Melphalan 3130-nm albumin-bound paclitaxel 3eribulin 2Thiotepa 2Tamoxifen 2Peripheral Blood Stem Cell Transplantation 2Lapatinib 2Fluorouracil 2Filgrastim 2Bevacizumab 22C4 antibody 2trastuzumab biosimilar HLX02 1talimogene laherparepvec 1sargramostim 1ruxolitinib 1romidepsin 1pegfilgrastim 1pazopanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Inflammatory Breast Neoplasms × aldesleukin × Clear all
NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡